Join
Materialise NV logo

MTLS

NASDAQ

Materialise NV

SectorTechnologyIndustryComputer Software: Prepackaged SoftwareIPO2014
$6.64+0.07 (+1.14%)
News25/Ratings6

Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. It operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Price$6.64+0.16 (+2.47%)
01:30 PM07:45 PM
News · 26 weeks33-58%
2025-12-14: 02025-12-21: 02025-12-28: 02026-01-04: 02026-01-11: 02026-01-18: 02026-01-25: 02026-02-01: 22026-02-08: 12026-02-15: 42026-02-22: 12026-03-01: 12026-03-08: 12026-03-15: 12026-03-22: 12026-03-29: 22026-04-05: 12026-04-12: 12026-04-19: 42026-04-26: 12026-05-03: 42026-05-10: 32026-05-17: 12026-05-24: 22026-05-31: 12026-06-07: 1
2025-12-142026-06-07
Mix2390d
  • SEC Filings17(74%)
  • Other4(17%)
  • Earnings2(9%)

Latest news

25 items

MTLS FAQ

7 questions
  • What does Materialise NV do?
    Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. It operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided...
  • Where does MTLS stock trade?
    Materialise NV (MTLS) is listed on NASDAQ.
  • What sector and industry is MTLS in?
    Materialise NV operates in the Technology sector, Computer Software: Prepackaged Software industry.
  • When did Materialise NV go public?
    Materialise NV (MTLS) completed its IPO in 2014.
  • What are analysts saying about MTLS?
    Materialise NV has had 6 recent analyst actions on file. The most recent action was from Cantor Fitzgerald: Overweight with a $950.00 price target on 2024-04-24. Recent price targets range from $950.00 to $3000.00.
  • What companies are similar to MTLS?
    Notable peers in the same industry include MSFT (Microsoft Corporation), ORCL (Oracle Corporation), SAP (SAP SE), CRWD (CrowdStrike Holdings Inc.), CRM (Salesforce Inc.). Compare MTLS side-by-side with any of them on Quantisnow.
  • How can I track MTLS on Quantisnow?
    Quantisnow aggregates Materialise NV's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MTLS to receive live email and push alerts on every new disclosure.